TFSA: Buy These 2 Stocks With the New $6,500 Room Limit in 2023

Canadians who want to utilize the $6,500 TFSA room limit in 2023 should look to promising stocks like Savaria (TSX:SIS).

| More on:
TFSA and coins

Image source: Getty Images

This past month, the Canadian government announced that the Tax-Free Savings Account (TFSA) would increase its annual room limit to $6,500 from the $6,000 it stood from 2019 through 2022. That will increase the cumulative contribution room in a TFSA to $88,000.

The S&P/TSX Composite Index fell 22 points to close out the previous week on Friday, December 9. The S&P/TSX Capped Health Care Index was one of the worst performers during this trading day and one of the worst to open the final month of 2022. However, this should not cast the broader healthcare space in a bad light. Cannabis stocks, which make up a huge portion of the healthcare index, have struggled mightily.

Today, I want to look at two stocks in the healthcare space that are worth spending that new room limit on.

Here’s why this personal mobility stock is perfect for your TFSA in 2023 and beyond

Savaria (TSX:SIS) is a Laval-based company that provides accessibility solutions for the elderly and physically challenged people in Canada, the United States, and around the world. Shares of this TSX stock have dropped 16% in 2022. The stock is up 17% year over year.

Canadian investors should be eager for exposure to the global personal accessibility industry. Grand View Research estimated that the global personal mobility devices market was worth US$14.9 billion in 2021. The report projects that this market will deliver a compound annual growth rate (CAGR) of 6.3% from 2022 through to the end of 2030.

This company released its third-quarter (Q3) fiscal 2022 results on November 2. Savaria delivered revenue growth of 11% to $201 million and gross profit jumped 9.3% to $64.0 million. Shares of this TSX stock were trading in favourable value territory at the time of this writing. This stock also offers a monthly dividend of $0.043 per share. That represents a 3.3% yield.

Savaria offers a shot at big growth and solid monthly income in your TFSA going forward.

TFSA investors: Don’t sleep on this nutrition and supplements giant

Jamieson Wellness (TSX:JWEL) is the second TSX stock I’d look to snatch up in our TFSA as we approach the midway point in December. This Toronto-based company is engaged in the development, manufacturing, distribution, marketing, and sale of natural health products in Canada and around the world. Jamieson stock has dropped 13% so far in 2022. Its shares are down 16% from the prior year.

TFSA investors should be eager to get in on the nutrition and supplements space. Facts and Factors recently estimated that the global dietary supplements market was valued at US$149 billion in 2021. It forecasts that this market will post a CAGR of 8.5% between 2022 and 2028 to a valuation of US$240 billion.

In Q3 2022, this company posted total revenue growth of 31% to $138 million. Jamieson reported adjusted net earnings of $14.2 million or $0.34 per share, which was largely flat compared to the prior year.

Shares of Jamieson possess a solid price-to-earnings ratio of 28. Meanwhile, it offers a quarterly dividend of $0.17 per share, which represents a 1.9% yield.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Ambrose O'Callaghan has positions in Jamieson Wellness. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

More on Investing

Nuclear power station cooling tower
Metals and Mining Stocks

If You’d Invested $1,000 in Cameco Stock 5 Years Ago, This Is How Much You’d Have Now

Cameco (TSX:CCO) stock still looks undervalued, despite a 258% rally. Can the uranium miner deliver more capital gains to shareholders?

Read more »

Businessman holding tablet and showing a growing virtual hologram of statistics, graph and chart with arrow up on dark background. Stock market. Business growth, planning and strategy concept
Dividend Stocks

TFSA Magic: Earn Enormous Passive Income That the CRA Can’t Touch

If you're seeking out passive income, with zero taxes involved, then get on board with a TFSA and this portfolio…

Read more »

Man with no money. Businessman holding empty wallet
Dividend Stocks

2 Stocks Under $50 New Investors Can Confidently Buy

There are some great stocks under $50 that every investor needs to know about. Here’s a look at two great…

Read more »

potted green plant grows up in arrow shape
Stocks for Beginners

3 Growth Stocks I’m Buying in April

These three growth stocks are up in the last year, and that is likely to continue on as we keep…

Read more »

clock time
Tech Stocks

Long-Term Investing: 3 Top Canadian Stocks You Can Buy for Under $20 a Share

These three under-$20 stocks offer excellent buying opportunities for long-term investors.

Read more »

Arrowings ascending on a chalkboard
Energy Stocks

Beat the TSX With This Cash-Gushing Dividend Stock

Canadian Natural Resources stock is well set up to beat the TSX as it continues to generate strong cash flows…

Read more »

think thought consider
Dividend Stocks

Down 10.88%: Is ATD Stock a Good Buy After Earnings?

Alimentation Couche-Tard (TSX:ATD) stock might not be the easy buy-case it once was. Here’s a look at what happened.

Read more »

money cash dividends
Dividend Stocks

TFSA Dividend Stocks: Earn $1,200/Year Tax-Free

Canadian stocks like Fortis are a must-have in your portfolio to earn tax-free yields for decades.

Read more »